Targeted next-generation sequencing for the detection of cancer-associated somatic mutations in adenomyosis

References

• Akaev, I., Yeoh, C.C., and Rahimi, S., 2021. Update on endometrial stromal tumours of the uterus. Diagnostics, 11 (3), 429.
   Web of Science ®Google Scholar
• Anglesio, M.S., et al., 2017. Cancer-associated mutations in endometriosis without cancer. New England Journal of Medicine, 376 (19), 1835–1848.
   PubMed Web of Science ®Google Scholar
• Arnold, J., et al., 2013. Neuroimmunomodulatory alterations in non-lesional peritoneum close to peritoneal endometriosis. Neuroimmunomodulation, 20 (1), 9–18.
   PubMed Web of Science ®Google Scholar
• Bailey, M.L., et al., 2014. Glioblastoma cells containing mutations in the cohesin component STAG2 are sensitive to PARP inhibition. Molecular Cancer Therapeutics, 13 (3), 724–732.
   PubMed Web of Science ®Google Scholar
• Barcena de Arellano, M.L., et al., 2013. Evidence of neurotrophic events due to peritoneal endometriotic lesions. Cytokine, 62 (2), 253–261.
   PubMed Web of Science ®Google Scholar
• Barcena de Arellano, M.L., et al., 2012. Eutopic endometrium from women with endometriosis does not exhibit neurotrophic properties. Journal of Neuroimmunology, 249 (1–2), 49–55.
   PubMed Web of Science ®Google Scholar
• Basak, S. and Saha, A., 2009. Adenomyosis: still largely under-diagnosed. Journal of Obstetrics and Gynaecology, 29 (6), 533–535.
   Web of Science ®Google Scholar
• Bergeron, C., Amant, F., and Ferenczy, A., 2006. Pathology and physiopathology of adenomyosis. Best Practice & Research. Clinical Obstetrics & Gynaecology, 20 (4), 511–521.
   PubMed Web of Science ®Google Scholar
• Bhagwate, A.V., et al., 2019. Bioinformatics and DNA-extraction strategies to reliably detect genetic variants from FFPE breast tissue samples. BMC Genomics, 20 (1), 689.
   PubMed Web of Science ®Google Scholar
• Bradley, L.D., Falcone, T., and Magen, A.B., 2000. Radiographic imaging techniques for the diagnosis of abnormal uterine bleeding. Obstetrics and Gynecology Clinics of North America, 27 (2), 245–276.
   PubMed Web of Science ®Google Scholar
• De Koninck, M. and Losada, A., 2016. Cohesin mutations in cancer. Cold Spring Harbor Perspectives in Medicine, 6 (12), a026476.
   PubMed Web of Science ®Google Scholar
• Ferenczy, A., 1998. Pathophysiology of adenomyosis. Human Reproduction Update, 4 (4), 312–322.
   PubMed Web of Science ®Google Scholar
• Guan, B., et al., 2012. Functional analysis of in-frame indel ARID1A mutations reveals new regulatory mechanisms of its tumor suppressor functions. Neoplasia, 14 (10), 986–993.
   PubMed Web of Science ®Google Scholar
• Hao, B., et al., 2007. Structure of a Fbw7–Skp1–cyclin E complex: multisite-phosphorylated substrate recognition by SCF ubiquitin ligases. Molecular Cell, 26 (1), 131–143.
   PubMed Web of Science ®Google Scholar
• Inoue, S., et al., 2019. Uterine adenomyosis is an oligoclonal disorder associated with KRAS mutations. Nature Communications, 10 (1), 5785.
   PubMedGoogle Scholar
• Krishnan, T., et al., 2022. Targeting mutated KRAS genes to treat solid tumours. Molecular Diagnosis & Therapy, 26 (1), 39–49.
   PubMed Web of Science ®Google Scholar
• Lagana, A.S., et al., 2020. Evaluation of M1 and M2 macrophages in ovarian endometriomas from women affected by endometriosis at different stages of the disease. Gynecological Endocrinology, 36 (5), 441–444.
   PubMed Web of Science ®Google Scholar
• Lagana, A.S., et al., 2018. Stem cell trafficking during endometriosis: may epigenetics play a pivotal role? Reproductive Sciences, 25 (7), 978–979.
   PubMed Web of Science ®Google Scholar
• Levgur, M., Abadi, M.A., and Tucker, A., 2000. Adenomyosis: symptoms, histology, and pregnancy terminations. Obstetrics and Gynecology, 95 (5), 688–691.
   PubMed Web of Science ®Google Scholar
• Li, X., et al., 2014. Whole-exome sequencing of endometriosis identifies frequent alterations in genes involved in cell adhesion and chromatin-remodeling complexes. Human Molecular Genetics, 23 (22), 6008–6021.
   PubMed Web of Science ®Google Scholar
• Li, Y.W., et al., 2018. Clinical manifestations of adenomyosis patients with or without coexisting endometriosis. Chinese Medical Journal, 131 (20), 2495–2498.
   PubMed Web of Science ®Google Scholar
• Reisman, D., Glaros, S., and Thompson, E.A., 2009. The SWI/SNF complex and cancer. Oncogene, 28 (14), 1653–1668.
   PubMed Web of Science ®Google Scholar
• Richards, S., et al., 2015. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in Medicine, 17 (5), 405–424.
   PubMed Web of Science ®Google Scholar
• Russo, M., et al., 2020. Mutational profile of endometrial hyperplasia and risk of progression to endometrioid adenocarcinoma. Cancer, 126 (12), 2775–2783.
   PubMed Web of Science ®Google Scholar
• Solomon, D.A., et al., 2011. Mutational inactivation of STAG2 causes aneuploidy in human cancer. Science, 333 (6045), 1039–1043.
   PubMed Web of Science ®Google Scholar
• Suda, K., et al., 2018. Clonal expansion and diversification of cancer-associated mutations in endometriosis and normal endometrium. Cell Reports, 24 (7), 1777–1789.
   PubMed Web of Science ®Google Scholar
• Sunkara, S.K. and Khan, K.S., 2012. Adenomyosis and female fertility: a critical review of the evidence. Journal of Obstetrics and Gynaecology, 32 (2), 113–116.
   Web of Science ®Google Scholar
• Tan, M.C., et al., 2015. GNAS and KRAS mutations define separate progression pathways in intraductal papillary mucinous neoplasm-associated carcinoma. Journal of the American College of Surgeons, 220 (5), 845–854.e1.
   PubMed Web of Science ®Google Scholar
• Vavilis, D., et al., 1997. Adenomyosis at hysterectomy: prevalence and relationship to operative findings and reproductive and menstrual factors. Clinical and Experimental Obstetrics & Gynecology, 24 (1), 36–38.
   PubMedGoogle Scholar
• Wang, P.P., et al., 2016. BAM-matcher: a tool for rapid NGS sample matching. Bioinformatics, 32 (17), 2699–2701.
   PubMed Web of Science ®Google Scholar
• Xu, C., et al., 2017. Detecting very low allele fraction variants using targeted DNA sequencing and a novel molecular barcode-aware variant caller. BMC Genomics, 18 (1), 5.
   PubMedGoogle Scholar
• Yeh, C.H., Bellon, M., and Nicot, C., 2018. FBXW7: a critical tumor suppressor of human cancers. Molecular Cancer, 17 (1), 115.
   PubMedGoogle Scholar
• Yetimalar, M.H., Kilic, D., and Bezircioglu, I. 2022. The impact of uterine adenomyosis on the histopathological risk factors and survival in patients with endometrial adenocarcinoma. Journal of Obstetrics and Gynaecology, 42, 1–7.
   Web of Science ®Google Scholar